Nurofen For Children Orange 200ml

Children 4 - 6 years: 7.5ml (5ml +2.5ml spoonful) may be taken 3 times in 24 hours. Children 7 - 9 years: Two 5ml doses may be taken 3 times in 24 hours. Children 10 - 12 years: Three 5ml doses may be taken 3 times in 24 hours.

Doses should be given approximately every 6 to 8 hours, (or with a minimum of 4 hours between each dose if required).

Not suitable for children under 3 months of age unless advised by your doctor.

For post immunisation pyrexia: One 2.5 ml dose followed by one further 2.5 ml dose 6 hours later if necessary. No more than two 2.5ml doses in 24 hours. If the fever is not reduced, consult your doctor.

For oral administration.

For short term use only. If the child's (aged over 6months) symptoms persist for more than 3 days, consult your doctor. For children under 6 months medical advice should be sought after 24 hours use (3 doses) if the symptoms persist.

Ibuprofen has been shown to have an onset of both analgesic and antipyretic action within 30 minutes.

Do not use if the patient has:

Hypersensitivity to ibuprofen or any of the constituents in the product.

Patients who have previously shown hypersensitivity reactions (e.g. asthma, rhinitis, angioedema or urticaria) in response to aspirin or other non-steroidal anti-inflammatory drugs.

Active or previous peptic ulcer.

History of upper gastrointestinal bleeding or perforation, related to previous NSAIDs therapy.

Use with concomitant NSAIDs.

Severe hepatic failure, renal failure or heart failure.

Bronchospasm may be precipitated in patients suffering from or with a previous history of bronchial asthma or allergic disease.

Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms

Chronic inflammatory intestinal disease (ulcerative colitis, Crohn's disease) - as these conditions may be exacerbated.

Hypertension and/or cardiac impairment as renal function may deteriorate and/or fluid retention occur.

Renal impairment as renal function may further deteriorate .

Hepatic dysfunction.

GI bleeding, ulceration or perforation, which can be fatal, has been reported with all NSAIDs at anytime during treatment, with or without warning symptoms or a previous history of serious GI events.

Patients with a history of GI toxicity, particularly when elderly, should report any unusual abdominal symptoms (especially GI bleeding) particularly in the initial stages of treatment.

When GI bleeding or ulceration occurs in patients receiving ibuprofen, the treatment should be withdrawn.

For OTC: Caution (discussion with doctor or pharmacist) is required prior to starting treatment in patients with a history of hypertension and/or heart failure as fluid retention, hypertension and oedema have been reported in association with NSAID therapy.

Clinical trial and epidemiological data suggest that use of ibuprofen, particularly at high doses (2400mg daily) and in long-term treatment may be associated with a small increased risk of arterial thrombotic events (for example myocardial infarction or stroke). Overall, epidemiological studies do not suggest that low dose ibuprofen (e.g. 1200mg daily) is associated with an increased risk of myocardial infarction.

Do not take if you

• have or have ever had a stomach ulcer, perforation or bleeding

• are allergic to ibuprofen or any other ingredient of the product, aspirin or other related painkillers

• are taking other NSAID painkillers, or aspirin with a daily dose above 75mg

• are in the last 3 months of pregnancy

Speak to a pharmacist or your doctor before taking this product if you have asthma , liver, heart, kidney or bowel problems are in the first 6 months of pregnancy.

If symptoms persist for more than 3 days consult your doctor. For children under 6 months, if the symptoms persist for more than 24 hours (3 doses) consult your doctor.

Do not use in pregnancy or breastfeeding unless advised by your doctor.

Keep out of reach of children.